Paul Fagan's Colleagues at ECM Therapeutics, Inc.
Paul Fagan's Contact Details
N/A
ECM Therapeutics, Inc.
Paul Fagan's Company Details
Advancing regenerative medicine through the development of a natural biomaterial that restores mother nature's template to treat disease and injury.ECM scaffolds, in solid form, have been successfully used in more than 10 million human patients to repair a variety of body systems such as musculoskeletal tissues, cardiovascular structures, and non-healing skin wounds, among others. These products have all received FDA clearance.ECM Therapeutics' patented ECM hydrogel technology allows for expanded, less invasive applications in multiple disease areas. The first clinical product, EsophaGel, treats Barrett's esophagus, a precancerous condition that currently has no effective therapy.